{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:43:48Z","timestamp":1787319828815,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jchf.2025.102512","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:05:23Z","timestamp":1750957523000},"page":"102512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Linking Chronic Kidney Disease to Incident Heart Failure and Adverse Cardiac Remodeling Through the Plasma Proteome"],"prefix":"10.1016","volume":"13","author":[{"given":"Leo F.","family":"Buckley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Dorbala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Lamberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Claggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan T.","family":"Demmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth F.","family":"Dubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8250-2607","authenticated-orcid":false,"given":"Rajat","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ganz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2399-4653","authenticated-orcid":false,"given":"Ron C.","family":"Hoogeveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amil M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2025.102512_bib1","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102512_bib2","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.jacc.2019.02.071","article-title":"Burden and outcomes of heart failure hospitalizations in adults with chronic kidney disease","volume":"73","author":"Bansal","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102512_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006259","article-title":"Kidney disease measures and left ventricular structure and function: the Atherosclerosis Risk in Communities study","volume":"6","author":"Matsushita","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2025.102512_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ahj.2020.12.008","article-title":"Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: results from the CREDENCE trial","volume":"233","author":"Sarraju","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2025.102512_bib5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jchf.2021.06.017","article-title":"Effects of dapagliflozin in patients with kidney disease, with and without heart failure","volume":"9","author":"McMurray","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102512_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCULATIONAHA.121.057983","article-title":"Finerenone reduces risk of incident heart failure in patients with chronic kidney disease and type 2 diabetes: analyses from the FIGARO-DKD trial","volume":"145","author":"Filippatos","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102512_bib7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/ejhf.2469","article-title":"Finerenone in patients with CKD and T2D with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial","volume":"24","author":"Filippatos","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102512_bib8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/science.aaq1327","article-title":"Co-regulatory networks of human serum proteins link genetics to disease","volume":"361","author":"Emilsson","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jchf.2025.102512_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.122.059678","article-title":"High-sensitivity cardiac troponin and the 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guidelines for the evaluation and diagnosis of acute chest pain","volume":"146","author":"Sandoval","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102512_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd3480","article-title":"How were new medicines discovered?","volume":"10","author":"Swinney","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jchf.2025.102512_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2025.102512_bib12","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin c-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102512_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/CIRCIMAGING.113.000736","article-title":"Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons","volume":"7","author":"Shah","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.jchf.2025.102512_bib14","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/01.ASN.0000070149.78399.CE","article-title":"The chronic renal insufficiency cohort (CRIC) study: design and methods","volume":"14","author":"Feldman","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2025.102512_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jchf.2025.102512_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-Plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2025.102512_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208042","article-title":"Proteomic analysis of heart failure hospitalization among patients with chronic kidney disease: the Heart and Soul Study","volume":"13","author":"Dubin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2025.102512_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016463","article-title":"Impact of kidney function on the blood proteome and on protein cardiovascular risk biomarkers in patients with stable coronary heart disease","volume":"9","author":"Yang","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2025.102512_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2020.06.013","article-title":"The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease","volume":"307","author":"Feldreich","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jchf.2025.102512_bib20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/FJC.0000000000001482","article-title":"Targeting pharmacotherapies for inflammatory and cardiorenal endpoints in kidney disease","volume":"83","author":"Huck","year":"2024","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jchf.2025.102512_bib21","doi-asserted-by":"crossref","first-page":"HEP22","DOI":"10.2217\/hep-2020-0006","article-title":"Recent advances of GOLM1 in hepatocellular carcinoma","volume":"7","author":"Yan","year":"2020","journal-title":"Hepat Oncol"},{"key":"10.1016\/j.jchf.2025.102512_bib22","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1600-0854.2007.00621.x","article-title":"Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma","volume":"8","author":"Bachert","year":"2007","journal-title":"Traffic"},{"key":"10.1016\/j.jchf.2025.102512_bib23","first-page":"34","article-title":"Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2)","volume":"2","author":"Wright","year":"2009","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jchf.2025.102512_bib24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1165\/rcmb.2023-0151OC","article-title":"GOLM1 promotes pulmonary fibrosis through upregulation of NEAT1","volume":"70","author":"Wang","year":"2024","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jchf.2025.102512_bib25","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/s41467-024-46135-9","article-title":"Deficiency of ASGR1 promotes liver injury by increasing GP73-mediated hepatic endoplasmic reticulum stress","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jchf.2025.102512_bib26","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.4139","article-title":"Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi","volume":"22","author":"Li","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.jchf.2025.102512_bib27","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2025.102512_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1681\/ASN.2020050595","article-title":"Ziltivekimab for treatment of anemia of inflammation in patients on hemodialysis: results from a phase 1\/2 multicenter, randomized, double-blind, placebo-controlled trial","volume":"32","author":"Pergola","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2025.102512_bib29","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrd.2016.278","article-title":"Therapeutic targeting of the angiopoietin-TIE pathway","volume":"16","author":"Saharinen","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jchf.2025.102512_bib30","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cardfail.2021.04.001","article-title":"Associations of angiopoietins with heart failure incidence and severity","volume":"27","author":"Peplinski","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2025.102512_bib31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1681\/ASN.2021060757","article-title":"Angiopoietins as prognostic markers for future kidney disease and heart failure events after acute kidney injury","volume":"33","author":"Mansour","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2025.102512_bib32","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1093\/eurheartj\/ehac495","article-title":"Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights from the EMPEROR program","volume":"43","author":"Zannad","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102512_bib33","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00125-022-05678-6","article-title":"Diabetes, GDF-15 and incident heart failure: the Atherosclerosis Risk In Communities study","volume":"65","author":"Echouffo-Tcheugui","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.jchf.2025.102512_bib34","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1373\/clinchem.2019.305797","article-title":"Cardiac and stress biomarkers and chronic kidney disease progression: the CRIC study","volume":"65","author":"Bansal","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.jchf.2025.102512_bib35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11897-023-00610-4","article-title":"Growth differentiation factor 15 (GDF-15), a new biomarker in heart failure management","volume":"20","author":"Sawalha","year":"2023","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jchf.2025.102512_bib36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s42255-021-00366-y","article-title":"Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation","volume":"3","author":"Weng","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.jchf.2025.102512_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201700067","article-title":"The impact of the glomerular filtration rate on the human plasma proteome","volume":"12","author":"Christensson","year":"2018","journal-title":"Proteomics Clin Appl"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925004391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925004391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:22:18Z","timestamp":1785554538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177925004391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2213177925004391"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102512","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linking Chronic Kidney Disease to Incident Heart Failure and Adverse Cardiac Remodeling Through the Plasma Proteome","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}],"article-number":"102512"}}